// App-Quantinova.ai

TCT-385 : The MADS Classification in Patients Undergoing Left Main Percutaneous Coronary Intervention: Technique Analysis From the IDEAL LM Trial

Researchers

Presenter

  • Chun-Chin Chang

Principal Investigators

  • Yoshinobu Onuma

  • Maciej Lesiak

  • Evgeny Merkulov

  • Richard Anderson

  • Evgeny Kretov

  • Paul Barragan

  • Keith Oldroyd

  • Robert-Jan van Geuns

Medical Centers

  • Radboud University Medical Center, Njmegen, Netherlands

  • Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands

  • Polyclinique les Fleurs, ollioules, France

  • Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland

  • National Medical Research Center named after E.N. Meshalkin, Novosibirsk, Russian Federation

  • University Hospital of Wales, Llanblethian, United Kingdom

  • West of Scotland Heart and Lung Centre, Golden Jubilee National Hospita, Glasgow, United Kingdom

  • National Medical Reasearch Center of Cardiology, Moscow, Russian Federation

Locations

  • Netherlands

  • France

  • Poland

  • Russia

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Left main disease

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved